Jinmiao Lu

1.4k total citations
70 papers, 1000 citations indexed

About

Jinmiao Lu is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Jinmiao Lu has authored 70 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Physiology and 9 papers in Infectious Diseases. Recurrent topics in Jinmiao Lu's work include Pharmacological Effects and Toxicity Studies (5 papers), COVID-19 Clinical Research Studies (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jinmiao Lu is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), COVID-19 Clinical Research Studies (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jinmiao Lu collaborates with scholars based in China, United States and Hong Kong. Jinmiao Lu's co-authors include Zhiping Li, Lili Wan, Cheng Guo, Quanjun Yang, Jinlu Huang, Yonglong Han, Yan Huo, Chao Peng, Xiao‐Jun Ji and Xiaoxia Li and has published in prestigious journals such as Bioresource Technology, Scientific Reports and Brain Research.

In The Last Decade

Jinmiao Lu

64 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinmiao Lu China 19 373 183 119 115 114 70 1000
Juan Chen China 25 506 1.4× 131 0.7× 119 1.0× 240 2.1× 76 0.7× 95 1.5k
T G Rosano United States 24 479 1.3× 112 0.6× 211 1.8× 136 1.2× 80 0.7× 71 1.8k
Ondřej Slanař Czechia 21 301 0.8× 76 0.4× 193 1.6× 94 0.8× 83 0.7× 162 1.3k
Anlin Peng China 19 431 1.2× 161 0.9× 140 1.2× 71 0.6× 253 2.2× 30 1.2k
Byung Hwa Jung South Korea 23 929 2.5× 154 0.8× 84 0.7× 176 1.5× 172 1.5× 83 1.6k
Jean‐Francois Marier United States 24 539 1.4× 331 1.8× 195 1.6× 205 1.8× 70 0.6× 72 2.0k
Tawar Qaradakhi Australia 15 356 1.0× 92 0.5× 126 1.1× 50 0.4× 130 1.1× 23 1.1k
Hyung‐Doo Park South Korea 19 487 1.3× 243 1.3× 57 0.5× 272 2.4× 106 0.9× 165 1.5k
Gowraganahalli Jagadeesh United States 20 665 1.8× 114 0.6× 89 0.7× 114 1.0× 102 0.9× 50 1.5k

Countries citing papers authored by Jinmiao Lu

Since Specialization
Citations

This map shows the geographic impact of Jinmiao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinmiao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinmiao Lu more than expected).

Fields of papers citing papers by Jinmiao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinmiao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinmiao Lu. The network helps show where Jinmiao Lu may publish in the future.

Co-authorship network of co-authors of Jinmiao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinmiao Lu. A scholar is included among the top collaborators of Jinmiao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinmiao Lu. Jinmiao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Wensheng, et al.. (2024). Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric patients with epilepsy: Model‐based dose optimization. Basic & Clinical Pharmacology & Toxicology. 134(5). 712–726. 2 indexed citations
3.
Lu, Jinmiao, Junqi Zhang, Guangfei Wang, Xiaobo Zhang, & Zhiping Li. (2023). Effects of bronchoalveolar lavage on Mycoplasma Pneumoniae pneumonia: A propensity score matched-cohort study. Frontiers in Pediatrics. 10. 1066640–1066640. 7 indexed citations
4.
Lu, Jinmiao, Xunjie Zhang, Hong Xu, & Zhiping Li. (2022). First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world. Human Vaccines & Immunotherapeutics. 18(5). 2080443–2080443. 1 indexed citations
5.
Lu, Jinmiao, et al.. (2022). Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology. Computational and Mathematical Methods in Medicine. 2022. 1–17. 8 indexed citations
6.
Zhuang, Tingting, et al.. (2022). Eukaryotic expression and immunogenicity of Ancylostoma ceylanicum calreticulin. Parasitology International. 91. 102633–102633.
7.
Lu, Jinmiao, et al.. (2022). Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model. Frontiers in Oncology. 12. 829798–829798. 4 indexed citations
8.
Lu, Jinmiao, et al.. (2021). Low-dose oral hydroxychloroquine led to impaired vision in a child with renal failure. Medicine. 100(10). e24919–e24919. 4 indexed citations
10.
Wang, Guangfei, Jinmiao Lu, Junqi Zhang, et al.. (2021). Exposure levels of mycophenolic acid are associated with comorbidities in children with systemic lupus erythematosus. Lupus. 30(11). 1808–1818. 3 indexed citations
11.
Shao, Jianbo, Hong Xu, Zhixi Liu, et al.. (2021). Factors associated with the time to return negative RT-PCR from COVID-19 in paediatric patients: a retrospective cohort study. BMJ Open. 11(10). e052609–e052609.
12.
Chen, Xiao, Dongdong Wang, Guangfei Wang, et al.. (2021). Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma. Frontiers in Pharmacology. 12. 668952–668952. 8 indexed citations
14.
Lu, Jinmiao, et al.. (2020). Clinical Pharmaceutical Care and Interpretation of Children with COVID-19. Zhōnghuá yàoxué zázhì. 55(10). 1 indexed citations
15.
Lu, Jinmiao, Min Dong, Dan Wu, et al.. (2016). Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants. European Journal of Clinical Pharmacology. 72(12). 1479–1488. 6 indexed citations
16.
Zhou, Zhiyong, Lili Wan, Quanjun Yang, et al.. (2016). Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model. Toxicology Letters. 259. 124–132. 31 indexed citations
17.
18.
Zhao, Tie, Jun He, Xiaoxue Wang, et al.. (2014). Rapid detection and characterization of major phenolic compounds in Radix Actinidia chinensis Planch by ultra-performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98. 311–320. 32 indexed citations
19.
Lu, Jinmiao, et al.. (2011). d‐Amino acid oxidase‐mediated increase in spinal hydrogen peroxide is mainly responsible for formalin‐induced tonic pain. British Journal of Pharmacology. 165(6). 1941–1955. 50 indexed citations
20.
Zhang, Xiaoxin, Jilong Wang, Quanhong Zhou, et al.. (2011). Brain-derived neurotrophic factor–activated astrocytes produce mechanical allodynia in neuropathic pain. Neuroscience. 199. 452–460. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026